Accuray Inc

Latest Accuray Inc News and Updates

  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon Treatment System Sees Emerging Market Demand

    Halcyon The Halcyon system, Varian Medical Systems’ (VAR) recently launched cancer treatment device, aims to simplify and enhance IMRT (image-guided volumetric intensity modulated radiotherapy). The device has received clearance by the FDA (US Food and Drug Administration). By next year, Varian expects to receive regulatory approvals for the device in China and Japan. For more information […]

    By Sarah Collins
  • uploads///VAR
    Company & Industry Overviews

    Here’s What Varian Medical Systems’ Valuation Trend Indicates

    Of the nine analysts covering Varian Medical Systems (VAR) stock, three have given it a “strong buy,” three have given it a “hold,” and three have given it a “sell.”

    By Kenneth Smith
  • uploads///objectives
    Company & Industry Overviews

    A Look at Varian Medical Systems’ Long-Term Objectives

    Varian Medical Systems (VAR) spun off its imaging components business into Varex Imaging in January 2017, thus strengthening its positioning in the oncology market.

    By Sarah Collins
  • uploads///profitability drivers
    Company & Industry Overviews

    Why Varian Medical Systems’ Profitability Is Improving

    Varian Medical Systems’ profitability In 3Q17, Varian Medical Systems reported a gross margin of approximately 44.5%, representing an 18-basis-point improvement in the quarter. YTD (year-to-date), the margin has improved by around 138 basis points. In 3Q17, the company’s Oncology Systems business witnessed a gross margin improvement of 200 basis points to reach 48.1% of the segment’s total […]

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Varian Medical Systems: Analyzing Its Stock Performance

    Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.

    By Sarah Collins
  • uploads///PERFORMANCE
    Company & Industry Overviews

    Varian Medical Systems Attempts to Improve Its Performance Growth

    Varian Medical Systems (VAR) raised its guidance for fiscal 2016 in the view of higher-than-expected 3Q16 results reported on July 27.

    By Sarah Collins
  • uploads///growth strategy
    Company & Industry Overviews

    Growth Strategies Driving Varian Medical Systems’ Revenue

    Varian Medical Systems has ventured into the proton therapy business and has a huge product pipeline in this area. The company generated approximately $300 million through its proton therapy business in 2015.

    By Sarah Collins
  • uploads///radiotherapy gaps
    Company & Industry Overviews

    Varian Medical Systems’ Growth Potential in Radiation Oncology

    Varian Medical Systems’ next big technology innovation will be high-definition radiotherapy, which is an intelligent treatment delivery system that aims to achieve 100% radiation exposure for the tumor.

    By Sarah Collins
  • uploads///business segments
    Company & Industry Overviews

    Where Does Varian Medical Systems Get Most of Its Revenue?

    Varian Medical Systems’ Imaging Components segment accounts for approximately 19% of the company’s total revenue. The segment reported a revenue decline of ~10% in 2015.

    By Sarah Collins
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.